Emergent BioSolutions Inc (EBS)
8.91
+0.14
(+1.60%)
USD |
NYSE |
Nov 05, 14:28
Emergent BioSolutions Free Cash Flow: 37.60M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | 37.60M |
| March 31, 2024 | -132.20M |
| December 31, 2023 | -257.90M |
| September 30, 2023 | -209.40M |
| June 30, 2023 | -358.70M |
| March 31, 2023 | -279.50M |
| December 31, 2022 | -149.90M |
| September 30, 2022 | 63.20M |
| June 30, 2022 | 126.60M |
| March 31, 2022 | 77.60M |
| December 31, 2021 | 96.10M |
| September 30, 2021 | 22.90M |
| June 30, 2021 | 120.90M |
| March 31, 2021 | 310.40M |
| December 31, 2020 | 395.00M |
| September 30, 2020 | 271.90M |
| June 30, 2020 | 194.00M |
| March 31, 2020 | 51.30M |
| December 31, 2019 | 101.10M |
| September 30, 2019 | -171.50M |
| June 30, 2019 | -5.20M |
| March 31, 2019 | 65.70M |
| December 31, 2018 | -30.30M |
| September 30, 2018 | 221.37M |
| June 30, 2018 | 95.63M |
| Date | Value |
|---|---|
| March 31, 2018 | 119.33M |
| December 31, 2017 | 153.30M |
| September 30, 2017 | 55.62M |
| June 30, 2017 | 43.54M |
| March 31, 2017 | -24.19M |
| December 31, 2016 | -21.60M |
| September 30, 2016 | 0.955M |
| June 30, 2016 | 81.68M |
| March 31, 2016 | 96.62M |
| December 31, 2015 | -2.295M |
| September 30, 2015 | 43.53M |
| June 30, 2015 | 26.42M |
| March 31, 2015 | 40.52M |
| December 31, 2014 | 81.64M |
| September 30, 2014 | 46.92M |
| June 30, 2014 | 13.04M |
| March 31, 2014 | 33.42M |
| December 31, 2013 | 54.95M |
| September 30, 2013 | 1.986M |
| June 30, 2013 | -1.38M |
| March 31, 2013 | -18.02M |
| December 31, 2012 | -14.20M |
| September 30, 2012 | 54.78M |
| June 30, 2012 | 5.619M |
| March 31, 2012 | -19.18M |
Free Cash Flow Range, Past 5 Years
-358.70M
Minimum
Jun 2023
395.00M
Maximum
Dec 2020
25.32M
Average
63.20M
Median
Sep 2022
Free Cash Flow Benchmarks
| Geovax Labs Inc | -23.00M |
| Tonix Pharmaceuticals Holding Corp | -75.58M |
| Abbott Laboratories | 6.486B |
| SIGA Technologies Inc | 73.77M |
| Chimerix Inc | -67.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 47.50M |
| Cash from Investing (Quarterly) | -4.60M |
| Cash from Financing (Quarterly) | -50.90M |
| Free Cash Flow Per Share (Quarterly) | 0.8156 |
| Free Cash Flow to Equity (Quarterly) | 86.60M |
| Free Cash Flow to Firm (Quarterly) | 67.66M |
| Free Cash Flow Yield | 8.09% |